"This guidance demonstrates how FDA will need to work across traditional product boundaries to guide the development of innovative new products."

Janet Woodcock, MD, director of FDA's Centers for Drug Research, on new guidelines for approvals of drug-eluting stents, "Long-awaited FDA draft puts regulatory bar higher for DES," pp. 1, 6.